Aaron Weitzman

The best of 2022 in stories; Vestar, OEP and Corsair talk high rates and inflation

PE Hub takes a look back at 2022's best stories.

Apollo PE leaders opine on 2023; Vestar bets you need help getting to sleep

A conversation with Michael Vaupen, managing director at Vestar Capital Partners, about its investment in Nox Health; David Sambur and Matt Nord, co-heads of private equity at Apollo, talk about the year ahead.

Vestar invested in Nox Health to help you get a good night's sleep

The investment fits Vestar’s strategy of improving health outcomes, lowering costs and enhancing patient experience.

Thoma Bravo closes Nearmap deal; inside Warburg’s $8.9bn sale of Summit Health-CityMD

Inside Warburg Pincus's sale of Summit Health-CityMD to Walgreens' VillageMD

While the urgent care provider wasn't for sale per se, Warburg knew it would attract the right buyer, Thomas “TJ” Carella told PE Hub.

Healthcare deals from Ascend, ACP and ZCG. Plus, PE heads back to the gym

After a Covid downturn, PE bets on the fitness sector.

What lies ahead for dealmakers in 2023? AE Industrial weighs in, as we launch a new Q&A series

AEI discusses M&A conditions in the A&D sector.

Ex-Apollo co-founder’s new firm is rising fast; Healthcare deals this week include Amulet Capital, Sheridan and Vance Street

26North backs ex-BlackRock exec's new venture firm Braven.

Inside Apax Partners’ sale of Kepro to Carlyle; and behind Bluejay’s backing of warehouse specialist BWT

Bluejay acquires warehouse firm BWT.

How Apax turned Kepro into a double-digit organic grower

‘The acquisitions of HID, EQ Health and iMedecs were each relatively small, but they gave Kepro really specific capabilities,’ according to Apax’s Cavanna.